A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

As celebrities from Rachel Sennott to Khloé Kardashian normalise beta blockers, a clinical drug is being reshaped into a ...

Rendering a drug effective or ineffective in a flash at the appropriate location—this is the focus of research in photopharmacology. The goal is to develop drugs that can be switched on and off with ...

Imagine you're about to give a presentation to a room full of people.

Researchers have found that amlodipine, a calcium-channel blocker prescribed to tens of millions of people for high blood ...

DMAA got banned for good reason, but that doesn't mean you're stuck with weak pre-workouts. The best alternatives today ...

Over the last 5 years, the share price of Beta Drugs has gained 59.68% CAGR. Over the past year, the corresponding return has been -38.64%. Beta Drugs’s current P/E of 28.82x helps give context to how ...

Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 and TGF-beta, as a treatment for advanced gastric cancer. The green light – ...

NDA submitted seeking approval of IGALMI® in the at-home (outpatient) setting for the treatment of acute agitation associated ...